Baird Maintains Outperform on Bio-Techne, Raises Price Target to $230

Baird maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $222 to $230.

Benzinga · 02/05/2020 14:08

Baird maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $222 to $230.